BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19557732)

  • 1. Computerized characterization of prostate cancer by fractal analysis in MR images.
    Lv D; Guo X; Wang X; Zhang J; Fang J
    J Magn Reson Imaging; 2009 Jul; 30(1):161-8. PubMed ID: 19557732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
    Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
    Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
    Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
    Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.
    Kim CK; Choi D; Park BK; Kwon GY; Lim HK
    J Magn Reson Imaging; 2008 Oct; 28(4):963-9. PubMed ID: 18821631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are signal intensity and homogeneity useful parameters for distinguishing between benign and malignant soft tissue masses on MR images? Objective evaluation by means of texture analysis.
    Mayerhoefer ME; Breitenseher M; Amann G; Dominkus M
    Magn Reson Imaging; 2008 Nov; 26(9):1316-22. PubMed ID: 18448302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Texture analysis for tissue discrimination on T1-weighted MR images of the knee joint in a multicenter study: Transferability of texture features and comparison of feature selection methods and classifiers.
    Mayerhoefer ME; Breitenseher MJ; Kramer J; Aigner N; Hofmann S; Materka A
    J Magn Reson Imaging; 2005 Nov; 22(5):674-80. PubMed ID: 16215966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
    Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
    Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.
    Kim JH; Kim JK; Park BW; Kim N; Cho KS
    J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging.
    Miao H; Fukatsu H; Ishigaki T
    Eur J Radiol; 2007 Feb; 61(2):297-302. PubMed ID: 17085002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
    Kim CK; Park BK; Lee HM
    J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractal analysis of two-dimensional vascularity in primary prostate cancer and surrounding non-tumoral parenchyma.
    Taverna G; Colombo P; Grizzi F; Franceschini B; Ceva-Grimaldi G; Seveso M; Giusti G; Piccinelli A; Graziotti P
    Pathol Res Pract; 2009; 205(7):438-44. PubMed ID: 19232838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-assisted analysis of peripheral zone prostate lesions using T2-weighted and dynamic contrast enhanced T1-weighted MRI.
    Vos PC; Hambrock T; Barenstz JO; Huisman HJ
    Phys Med Biol; 2010 Mar; 55(6):1719-34. PubMed ID: 20197602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions.
    Hom JJ; Coakley FV; Simko JP; Qayyum A; Lu Y; Schmitt L; Carroll PR; Kurhanewicz J
    Radiology; 2006 Jan; 238(1):192-9. PubMed ID: 16373767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
    Hambrock T; Fütterer JJ; Huisman HJ; Hulsbergen-vandeKaa C; van Basten JP; van Oort I; Witjes JA; Barentsz JO
    Invest Radiol; 2008 Oct; 43(10):686-94. PubMed ID: 18791410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
    Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
    J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Description of magnetic resonance imaging-derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions.
    Zelhof B; Lowry M; Rodrigues G; Kraus S; Turnbull L
    BJU Int; 2009 Sep; 104(5):621-7. PubMed ID: 19281464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of MR images of breast masses with fractal-interpolation function models.
    Penn AI; Bolinger L; Schnall MD; Loew MH
    Acad Radiol; 1999 Mar; 6(3):156-63. PubMed ID: 10898034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.